-
2
-
-
0034296244
-
Gene therapy vectors based on adeno-associated virus: Characteristics and applications to acquired and inherited diseases
-
Athanasopoulos T, Fabb S, Dickson G. Gene therapy vectors based on adeno-associated virus: characteristics and applications to acquired and inherited diseases. Int J Mol Med 2000; 6: 363-375.
-
(2000)
Int. J. Mol. Med.
, vol.6
, pp. 363-375
-
-
Athanasopoulos, T.1
Fabb, S.2
Dickson, G.3
-
3
-
-
0034219436
-
Adeno-associated viral vectors as gene delivery vehicles
-
Carter BJ, Samulski RJ. Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 2000; 6: 17-27.
-
(2000)
Int. J. Mol. Med.
, vol.6
, pp. 17-27
-
-
Carter, B.J.1
Samulski, R.J.2
-
4
-
-
0035168925
-
Hot topics in adeno-associated virus as a gene transfer vector
-
Zhao N, Liu DP, Liang CC. Hot topics in adeno-associated virus as a gene transfer vector. Mol Biotechnol 2001; 19: 229-237.
-
(2001)
Mol. Biotechnol.
, vol.19
, pp. 229-237
-
-
Zhao, N.1
Liu, D.P.2
Liang, C.C.3
-
5
-
-
0037765800
-
AAV has minimal effects on cellular gene expression compared to other viruses examined using high density microarrays
-
[abstract]
-
Stilwell J, Samulski RJ. AAV has minimal effects on cellular gene expression compared to other viruses examined using high density microarrays [abstract]. Mol Ther 2001; 3: S131.
-
(2001)
Mol. Ther.
, vol.3
-
-
Stilwell, J.1
Samulski, R.J.2
-
6
-
-
0032977833
-
Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration
-
Brockstedt DG et al. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin Immunol 1999; 92: 67-75.
-
(1999)
Clin. Immunol.
, vol.92
, pp. 67-75
-
-
Brockstedt, D.G.1
-
7
-
-
0030819372
-
Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D
-
Manning WC et al. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J Virol 1997; 71: 7960-7962.
-
(1997)
J. Virol.
, vol.71
, pp. 7960-7962
-
-
Manning, W.C.1
-
8
-
-
0033994625
-
Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer
-
Liu D et al. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J Virol 2000; 74: 2888-2894.
-
(2000)
J. Virol.
, vol.74
, pp. 2888-2894
-
-
Liu, D.1
-
9
-
-
0034921072
-
A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus
-
Xin KQ et al. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum Gene Ther 2001; 12: 1047-1061.
-
(2001)
Hum. Gene Ther.
, vol.12
, pp. 1047-1061
-
-
Xin, K.Q.1
-
10
-
-
0036147989
-
Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells
-
Chiriva-Internati M et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur J Immunol 2002; 32: 30-38.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 30-38
-
-
Chiriva-Internati, M.1
-
11
-
-
0035207017
-
Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adenoassociated virus vector
-
Liu Y et al. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adenoassociated virus vector. Cancer Gene Ther 2001; 8: 948-957.
-
(2001)
Cancer Gene Ther.
, vol.8
, pp. 948-957
-
-
Liu, Y.1
-
12
-
-
0036605994
-
Immunogenicity of a p210BCR-ABL fusion domain candidate DNA vaccine targeted to dendritic cells by an rAAV vector in vitro
-
Sun J et al. Immunogenicity of a p210BCR-ABL fusion domain candidate DNA vaccine targeted to dendritic cells by an rAAV vector in vitro. Cancer Res 2002; 62: 3175-3183.
-
(2002)
Cancer Res.
, vol.62
, pp. 3175-3183
-
-
Sun, J.1
-
13
-
-
0038103349
-
Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy
-
Sun J, Chatterjee S, Wong Jr KK. Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy Curr Gene Ther 2002; 2: 485-500.
-
(2002)
Curr. Gene Ther.
, vol.2
, pp. 485-500
-
-
Sun, J.1
Chatterjee, S.2
Wong K.K., Jr.3
-
15
-
-
0038442531
-
-
Fields BN, Knipe DM, Howley, PM (eds.). 4th edn, Lippincott, Philadelphia
-
Muzyczka N, Berns KI. (2001) In: Fields BN, Knipe DM, Howley, PM (eds.). Parvoviruses in Virology, 4th edn, Lippincott, Philadelphia, pp 2327-2360.
-
(2001)
Parvoviruses in Virology
, pp. 2327-2360
-
-
Muzyczka, N.1
Berns, K.I.2
-
16
-
-
0034608803
-
Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model
-
Meyers C et al. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology 2002; 272: 338-346.
-
(2002)
Virology
, vol.272
, pp. 338-346
-
-
Meyers, C.1
-
17
-
-
0025214094
-
Site-specific integration by adeno-associated virus
-
Kotin et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990; 87: 2211-2215.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 2211-2215
-
-
Kotin, A.1
-
18
-
-
0031906147
-
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
-
Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
-
(1998)
J. Virol.
, vol.72
, pp. 1438-1445
-
-
Summerford, C.1
Samulski, R.J.2
-
19
-
-
0032589751
-
Alpha Vbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection
-
Summerford C, Bartlett JS, Samulski RJ. Alpha Vbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999; 5: 78-82.
-
(1999)
Nat. Med.
, vol.5
, pp. 78-82
-
-
Summerford, C.1
Bartlett, J.S.2
Samulski, R.J.3
-
20
-
-
0033010884
-
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
-
Qing K et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999; 5: 71-77.
-
(1999)
Nat. Med.
, vol.5
, pp. 71-77
-
-
Qing, K.1
-
21
-
-
0029849257
-
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
-
Dong JY, Fan PD, Frizzell RA. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther 1996; 7: 2101-2112.
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 2101-2112
-
-
Dong, J.Y.1
Fan, P.D.2
Frizzell, R.A.3
-
22
-
-
0033541640
-
Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
-
Clark KR, Liu X, McGrath JP, Johnson PR. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther 1999; 10: 1031-1039.
-
(1999)
Hum. Gene Ther.
, vol.10
, pp. 1031-1039
-
-
Clark, K.R.1
Liu, X.2
McGrath, J.P.3
Johnson, P.R.4
-
23
-
-
0033022953
-
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
-
Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973-985.
-
(1999)
Gene Therapy
, vol.6
, pp. 973-985
-
-
Zolotukhin, S.1
-
24
-
-
0032853699
-
Immune responses to adenovirus and adeno-associated virus in humans
-
Chirmule N et al. Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy 1999; 6: 1574-1583.
-
(1999)
Gene Therapy
, vol.6
, pp. 1574-1583
-
-
Chirmule, N.1
-
25
-
-
0031969428
-
Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
-
Jooss K, Yang Y, Fisher KJ, Wilson JM. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 1998; 72: 4212-4223.
-
(1998)
J. Virol.
, vol.72
, pp. 4212-4223
-
-
Jooss, K.1
Yang, Y.2
Fisher, K.J.3
Wilson, J.M.4
-
26
-
-
0033977047
-
Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle
-
Chirmule N et al. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol 2000; 74: 2420-2425.
-
(2000)
J. Virol.
, vol.74
, pp. 2420-2425
-
-
Chirmule, N.1
-
27
-
-
0032826773
-
Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model
-
Hernandez YJ et al. Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model. J Virol 1999; 73: 8549-8558.
-
(1999)
J. Virol.
, vol.73
, pp. 8549-8558
-
-
Hernandez, Y.J.1
-
28
-
-
0031743947
-
Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure
-
Halbert CL, Standaert TA, Wilson CB, Miller AD. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998; 72: 9795-9805.
-
(1998)
J. Virol.
, vol.72
, pp. 9795-9805
-
-
Halbert, C.L.1
Standaert, T.A.2
Wilson, C.B.3
Miller, A.D.4
-
29
-
-
0032031816
-
Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors
-
Manning et al. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum Gene Ther 1998; 9: 477-485.
-
(1998)
Hum. Gene Ther.
, vol.9
, pp. 477-485
-
-
Manning, A.1
-
30
-
-
0034169676
-
Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors
-
Xiao W et al. Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther 2000; 1: 323-329.
-
(2000)
Mol. Ther.
, vol.1
, pp. 323-329
-
-
Xiao, W.1
-
31
-
-
0028790247
-
The immune response and the eye. TCR-alpha chain related molecules regulate the systemic immunity to antigen presented in the eye
-
Griffith TS et al. The immune response and the eye. TCR-alpha chain related molecules regulate the systemic immunity to antigen presented in the eye. Int Immunol 1995; 7: 1617-1625.
-
(1995)
Int. Immunol.
, vol.7
, pp. 1617-1625
-
-
Griffith, T.S.1
-
32
-
-
0034122206
-
In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation
-
Kezuka T, Streilein JW. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 2000; 41: 1803-1811.
-
(2000)
Invest. Ophthalmol. Vis. Sci.
, vol.41
, pp. 1803-1811
-
-
Kezuka, T.1
Streilein, J.W.2
-
33
-
-
0036166251
-
A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus
-
Anand V et al. A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. Mol Ther 2002; 5: 125-132.
-
(2002)
Mol. Ther.
, vol.5
, pp. 125-132
-
-
Anand, V.1
-
34
-
-
0014247830
-
Serologic evidence for human infection with adenovirus-associated viruses
-
Blacklow NR, Hoggan MD, Rowe WP. Serologic evidence for human infection with adenovirus-associated viruses. J Natl Cancer Inst 1968; 40: 319-327.
-
(1968)
J. Natl. Cancer Inst.
, vol.40
, pp. 319-327
-
-
Blacklow, N.R.1
Hoggan, M.D.2
Rowe, W.P.3
-
35
-
-
0015144322
-
A seroepidemiologic study of adenovirus-associated virus infection in infants and children
-
Blacklow NR et al. A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am J Epidemiol 1971; 94: 359-366.
-
(1971)
Am. J. Epidemiol.
, vol.94
, pp. 359-366
-
-
Blacklow, N.R.1
-
36
-
-
0021340974
-
Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus
-
Georg-Fries B, Biederlack S, Wolf J, zur Hausen H. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 1984; 134: 64-71.
-
(1984)
Virology
, vol.134
, pp. 64-71
-
-
Georg-Fries, B.1
Biederlack, S.2
Wolf, J.3
zur Hausen, H.4
-
37
-
-
0345411588
-
Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)
-
Erles K, Sebokova P, Schlehofer JR. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999; 59: 406-411.
-
(1999)
J. Med. Virol.
, vol.59
, pp. 406-411
-
-
Erles, K.1
Sebokova, P.2
Schlehofer, J.R.3
-
38
-
-
0030797433
-
Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins
-
Hermanns J et al. Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J Virol 1997; 71: 6020-6027.
-
(1997)
J. Virol.
, vol.71
, pp. 6020-6027
-
-
Hermanns, J.1
-
39
-
-
0035974901
-
Virus-mediated killing of cells that lack p53 activity
-
Raj K, Ogston P, Beard P. Virus-mediated killing of cells that lack p53 activity. Nature 2001; 412: 914-917.
-
(2001)
Nature
, vol.412
, pp. 914-917
-
-
Raj, K.1
Ogston, P.2
Beard, P.3
-
40
-
-
0028281022
-
The tumor suppressive properties of adeno-associated viruses
-
Schlehofer JR. The tumor suppressive properties of adeno-associated viruses. Mutat Res 1994; 305: 303-313.
-
(1994)
Mutat. Res.
, vol.305
, pp. 303-313
-
-
Schlehofer, J.R.1
-
41
-
-
0035229222
-
Gene therapy: Recombinant adeno-associated virus vectors
-
Smith-Arica JR, Bartlett JS. Gene therapy: recombinant adeno-associated virus vectors. Curr Cardiol Rep 2001; 3: 43-49.
-
(2001)
Curr. Cardiol. Rep.
, vol.3
, pp. 43-49
-
-
Smith-Arica, J.R.1
Bartlett, J.S.2
-
42
-
-
0034897484
-
Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphoma
-
Walz CM et al. Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphoma. J Med Virol 2001; 65: 185-189.
-
(2001)
J. Med. Virol.
, vol.65
, pp. 185-189
-
-
Walz, C.M.1
-
43
-
-
0032924185
-
Gene therapy vectors based on adeno-associated virus type 1
-
Xiao W et al. Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994-4003.
-
(1999)
J. Virol.
, vol.73
, pp. 3994-4003
-
-
Xiao, W.1
-
44
-
-
0033920298
-
Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: Implications for gene therapy and virus structure
-
Moskalenko M et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J Virol 2000; 74: 1761-1766.
-
(2000)
J. Virol.
, vol.74
, pp. 1761-1766
-
-
Moskalenko, M.1
-
45
-
-
0033960160
-
Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
-
Halbert CL et al. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000; 74: 1524-1532.
-
(2000)
J. Virol.
, vol.74
, pp. 1524-1532
-
-
Halbert, C.L.1
-
46
-
-
0034968125
-
Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer
-
Hildinger M et al. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001; 75: 6199-6203.
-
(2001)
J. Virol.
, vol.75
, pp. 6199-6203
-
-
Hildinger, M.1
-
47
-
-
0032853032
-
Repeated delivery of adeno-associated virus vectors to the rabbit airway
-
Beck SE et al. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol 1999; 73: 9446-9455.
-
(1999)
J. Virol.
, vol.73
, pp. 9446-9455
-
-
Beck, S.E.1
-
48
-
-
0034628570
-
Additional transduction events after subretinal readministration of recombinant adeno-associated virus
-
Anand V et al. Additional transduction events after subretinal readministration of recombinant adeno-associated virus. Hum Gene Ther 2000; 11: 449-57.
-
(2000)
Hum. Gene Ther.
, vol.11
, pp. 449-457
-
-
Anand, V.1
-
49
-
-
0031058024
-
Recombinant adeno-associated virus for muscle directed gene therapy
-
Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy Nat Med 1997; 3: 306-312.
-
(1997)
Nat. Med.
, vol.3
, pp. 306-312
-
-
Fisher, K.J.1
-
50
-
-
0034050904
-
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
-
Kay MA et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257-261.
-
(2000)
Nat. Genet.
, vol.24
, pp. 257-261
-
-
Kay, M.A.1
-
51
-
-
0031984786
-
Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2
-
Rutledge EA, Halbert CL, Russell DW. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309-319.
-
(1998)
J. Virol.
, vol.72
, pp. 309-319
-
-
Rutledge, E.A.1
Halbert, C.L.2
Russell, D.W.3
-
52
-
-
0037015049
-
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
-
Gao GP et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854-11859.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 11854-11859
-
-
Gao, G.P.1
-
53
-
-
0031894064
-
Discrimination between different types of human adeno-associated viruses in clinical samples by PCR
-
Tobiasch E et al. Discrimination between different types of human adeno-associated viruses in clinical samples by PCR. J Virol Methods 1998; 71: 17-25.
-
(1998)
J. Virol. Methods
, vol.71
, pp. 17-25
-
-
Tobiasch, E.1
-
54
-
-
0034724209
-
Recombinant adeno-associated virus type 2,4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
-
Davidson BL et al. Recombinant adeno-associated virus type 2,4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428-3432.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 3428-3432
-
-
Davidson, B.L.1
-
55
-
-
0036140216
-
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity
-
Rabinowitz JE et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801.
-
(2002)
J. Virol.
, vol.76
, pp. 791-801
-
-
Rabinowitz, J.E.1
-
56
-
-
0034842912
-
Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vector
-
Chao H et al. Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vector. Mol Ther 2001; 4: 217-222.
-
(2001)
Mol. Ther.
, vol.4
, pp. 217-222
-
-
Chao, H.1
-
57
-
-
0028222954
-
Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes
-
Philip R et al. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol Cell Biol 1994; 14: 2411-2418.
-
(1994)
Mol. Cell Biol.
, vol.14
, pp. 2411-2418
-
-
Philip, R.1
-
58
-
-
0031727714
-
Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors
-
Fan L et al. Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors. Gene Therapy 1998; 5: 1434-1440.
-
(1998)
Gene Therapy
, vol.5
, pp. 1434-1440
-
-
Fan, L.1
-
59
-
-
0029797538
-
Expression of the human multidrug resistance and glucocerebrosidase cDNAs from adeno-associated vectors: Efficient promoter activity of AAV sequences and in vivo delivery via liposomes
-
Baudard M et al. Expression of the human multidrug resistance and glucocerebrosidase cDNAs from adeno-associated vectors: efficient promoter activity of AAV sequences and in vivo delivery via liposomes. Hum Gene Ther 1996; 7: 1309-1322.
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 1309-1322
-
-
Baudard, M.1
-
60
-
-
0033370798
-
Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension
-
Tang X et al. Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension. Am J Physiol 1999; 277: H2392-H2399.
-
(1999)
Am. J. Physiol.
, vol.277
-
-
Tang, X.1
-
61
-
-
0028060363
-
Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors
-
Podsakoff G, Wong Jr KK, Chatterjee S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 1994; 68: 5656-5666.
-
(1994)
J. Virol.
, vol.68
, pp. 5656-5666
-
-
Podsakoff, G.1
Wong K.K., Jr.2
Chatterjee, S.3
-
62
-
-
0030914867
-
Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment
-
Bradford GB, Williams B, Rossi R, Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol 1997; 25: 445-453.
-
(1997)
Exp. Hematol.
, vol.25
, pp. 445-453
-
-
Bradford, G.B.1
Williams, B.2
Rossi, R.3
Bertoncello, I.4
-
63
-
-
0036493384
-
Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients
-
Jetmore A et al. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood 2002; 99: 1585-1593.
-
(2002)
Blood
, vol.99
, pp. 1585-1593
-
-
Jetmore, A.1
-
64
-
-
0029945425
-
Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction
-
Fisher-Adams G et al. Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood 1996; 88: 492-504.
-
(1996)
Blood
, vol.88
, pp. 492-504
-
-
Fisher-Adams, G.1
-
65
-
-
0030879933
-
Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation
-
Ponnazhagan S et al. Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation. J Virol 1997; 71: 8262-8267.
-
(1997)
J. Virol.
, vol.71
, pp. 8262-8267
-
-
Ponnazhagan, S.1
-
66
-
-
0033559749
-
Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors
-
Chatterjee S et al. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 1999; 93: 1882-1894.
-
(1999)
Blood
, vol.93
, pp. 1882-1894
-
-
Chatterjee, S.1
-
67
-
-
0033995253
-
Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV
-
Nathwani AC et al. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. Gene Therapy 2000; 7: 183-195.
-
(2000)
Gene Therapy
, vol.7
, pp. 183-195
-
-
Nathwani, A.C.1
-
68
-
-
0034952156
-
Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice
-
Tan M et al. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice. Mol Ther 2001; 3: 940-946.
-
(2001)
Mol. Ther.
, vol.3
, pp. 940-946
-
-
Tan, M.1
-
69
-
-
0036149232
-
A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells
-
Shayakhmetov DM et al. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells. J Virol 2002; 76: 1135-1143.
-
(2002)
J. Virol.
, vol.76
, pp. 1135-1143
-
-
Shayakhmetov, D.M.1
-
70
-
-
0032870158
-
Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2
-
Girod A et al. Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2. Nat Med 1999; 5: 1052-1056.
-
(1999)
Nat. Med.
, vol.5
, pp. 1052-1056
-
-
Girod, A.1
-
71
-
-
0034814413
-
Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors
-
Shi W, Arnold GS, Bartlett JS. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum Gene Ther 2001; 12: 1697-1711.
-
(2001)
Hum. Gene Ther.
, vol.12
, pp. 1697-1711
-
-
Shi, W.1
Arnold, G.S.2
Bartlett, J.S.3
-
72
-
-
0033808531
-
Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: Epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection
-
Wobus CE et al. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J Virol 2000; 74: 9281-993.
-
(2000)
J. Virol.
, vol.74
, pp. 9281-9993
-
-
Wobus, C.E.1
-
73
-
-
0036678455
-
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
-
Xie Q et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 10405-10410.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 10405-10410
-
-
Xie, Q.1
-
74
-
-
0030984335
-
Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver
-
Kay M et al. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver, Proc Natl Acad Sci USA 1997; 94: 4686-4691.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 4686-4691
-
-
Kay, M.1
-
75
-
-
0034853102
-
Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9
-
Fields PA et al. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9. Mol Ther 2001; 4: 201-210.
-
(2001)
Mol. Ther.
, vol.4
, pp. 201-210
-
-
Fields, P.A.1
-
76
-
-
0030902985
-
Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
-
Herzog RW et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997; 94: 5804-5809.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 5804-5809
-
-
Herzog, R.W.1
-
77
-
-
17444387438
-
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
-
Herzog RW et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 5: 56-63.
-
(1999)
Nat. Med.
, vol.5
, pp. 56-63
-
-
Herzog, R.W.1
-
78
-
-
0030997346
-
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
-
Snyder RO et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270-276.
-
(1997)
Nat. Genet.
, vol.16
, pp. 270-276
-
-
Snyder, R.O.1
-
79
-
-
17444372024
-
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors
-
Snyder RO et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 1999; 5: 64-70.
-
(1999)
Nat. Med.
, vol.5
, pp. 64-70
-
-
Snyder, R.O.1
-
80
-
-
0034137797
-
Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver
-
Wang L et al. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol Ther 2000; 1: 154-158.
-
(2000)
Mol. Ther.
, vol.1
, pp. 154-158
-
-
Wang, L.1
-
81
-
-
0035877984
-
Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX
-
Ge Y, Powell S, Van Roey M, McArthur JG. Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX. Blood 2001; 97: 3733-3737.
-
(2001)
Blood
, vol.97
, pp. 3733-3737
-
-
Ge, Y.1
Powell, S.2
Van Roey, M.3
McArthur, J.G.4
-
82
-
-
0034849318
-
Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation
-
Herzog RW et al. Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation. Mol Ther 2001; 4: 192-200.
-
(2001)
Mol. Ther.
, vol.4
, pp. 192-200
-
-
Herzog, R.W.1
-
83
-
-
0037089331
-
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
-
Mount JD et al. Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 2002; 99: 2670-2676.
-
(2002)
Blood
, vol.99
, pp. 2670-2676
-
-
Mount, J.D.1
-
84
-
-
13144305062
-
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
-
Song S et al. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci USA 1998; 95: 14384-14388.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 14384-14388
-
-
Song, S.1
-
85
-
-
0036227449
-
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
-
Zaiss AK et al. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002; 76: 4580-4590.
-
(2002)
J. Virol.
, vol.76
, pp. 4580-4590
-
-
Zaiss, A.K.1
-
86
-
-
0031011987
-
Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice
-
Ponnazhagan S et al. Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 1997; 190: 203-210.
-
(1997)
Gene
, vol.190
, pp. 203-210
-
-
Ponnazhagan, S.1
-
87
-
-
0029843596
-
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
-
Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70: 8098-8108.
-
(1996)
J. Virol.
, vol.70
, pp. 8098-8108
-
-
Xiao, X.1
Li, J.2
Samulski, R.J.3
-
88
-
-
0034151775
-
Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX
-
Fields PA et al. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. Mol Ther 2000; 1: 225-235.
-
(2000)
Mol. Ther.
, vol.1
, pp. 225-235
-
-
Fields, P.A.1
-
89
-
-
0034749458
-
Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors
-
Sarukhan A et al. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol 2001; 75: 269-277.
-
(2001)
J. Virol.
, vol.75
, pp. 269-277
-
-
Sarukhan, A.1
-
90
-
-
0033882190
-
CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: Role of immature dendritic cells
-
Zhang Y, Chirmule N, Gao G, Wilson J. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells. J Virol 2000; 74: 8003-8010.
-
(2000)
J. Virol.
, vol.74
, pp. 8003-8010
-
-
Zhang, Y.1
Chirmule, N.2
Gao, G.3
Wilson, J.4
-
91
-
-
0035346104
-
Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors
-
Sarukhan A, Soudais C, Danos O, Jooss K. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med 2001; 3: 260-270.
-
(2001)
J. Gene Med.
, vol.3
, pp. 260-270
-
-
Sarukhan, A.1
Soudais, C.2
Danos, O.3
Jooss, K.4
-
92
-
-
13344261952
-
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
-
Riddell SR et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 1996; 2: 216-223.
-
(1996)
Nat. Med.
, vol.2
, pp. 216-223
-
-
Riddell, S.R.1
-
93
-
-
0034828903
-
Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors
-
Song S et al. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 2001; 8: 1299-1306.
-
(2001)
Gene Therapy
, vol.8
, pp. 1299-1306
-
-
Song, S.1
-
94
-
-
0035956882
-
Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice
-
Jung SC et al. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proc Natl Acad Sci USA 2001; 98: 2676-2681.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 2676-2681
-
-
Jung, S.C.1
-
95
-
-
17944388584
-
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
-
During MJ et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy Science 2000; 287: 1453-1460.
-
(2000)
Science
, vol.287
, pp. 1453-1460
-
-
During, M.J.1
-
96
-
-
0035915778
-
Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies
-
Cordier L et al. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum Gene Ther 2001; 12: 205-215.
-
(2001)
Hum. Gene Ther.
, vol.12
, pp. 205-215
-
-
Cordier, L.1
-
97
-
-
0036892308
-
Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product
-
Yuasa K et al. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Therapy 2002; 9: 1576-1588.
-
(2002)
Gene Therapy
, vol.9
, pp. 1576-1588
-
-
Yuasa, K.1
-
98
-
-
0033587482
-
Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors
-
Pastore L et al. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors. Hum Gene Ther 1999; 10: 1773-1781.
-
(1999)
Hum. Gene Ther.
, vol.10
, pp. 1773-1781
-
-
Pastore, L.1
-
99
-
-
0030915310
-
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
-
Bronte V et al. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci USA 1997; 94: 3183-3188.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 3183-3188
-
-
Bronte, V.1
-
100
-
-
0031838721
-
Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver
-
Nakai H et al. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 1998; 91: 4600-4607.
-
(1998)
Blood
, vol.91
, pp. 4600-4607
-
-
Nakai, H.1
-
101
-
-
0035282898
-
Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA
-
Nathwani AC et al. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood 2001; 97: 1258-1265.
-
(2001)
Blood
, vol.97
, pp. 1258-1265
-
-
Nathwani, A.C.1
-
102
-
-
0035937316
-
CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice
-
Xu L et al. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum Gene Ther 2001; 12: 563-573.
-
(2001)
Hum. Gene Ther.
, vol.12
, pp. 563-573
-
-
Xu, L.1
-
103
-
-
0035080378
-
Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice
-
Fields PA et al. Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice. Gene Therapy 2001; 8: 354-361.
-
(2001)
Gene Therapy
, vol.8
, pp. 354-361
-
-
Fields, P.A.1
-
104
-
-
0034161486
-
Sustained expression of human factor VIII in mice using a parvovirus-based vector
-
Chao H, Mao L, Bruce AT, Walsh CE. Sustained expression of human factor VIII in mice using a parvovirus-based vector. Blood 2000; 95: 1594-1599.
-
(2000)
Blood
, vol.95
, pp. 1594-1599
-
-
Chao, H.1
Mao, L.2
Bruce, A.T.3
Walsh, C.E.4
-
105
-
-
0036376642
-
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy
-
Herzog RW et al. Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy. Hum Gene Ther 2002; 13: 1281-1291.
-
(2002)
Hum. Gene Ther.
, vol.13
, pp. 1281-1291
-
-
Herzog, R.W.1
-
106
-
-
0035874523
-
Induction of tolerance to human factor VIII in mice
-
Chao H, Walsh CE. Induction of tolerance to human factor VIII in mice. Blood 2001; 97: 3311-3312.
-
(2001)
Blood
, vol.97
, pp. 3311-3312
-
-
Chao, H.1
Walsh, C.E.2
-
107
-
-
0033021870
-
In utero gene therapy: The case against
-
Billings PR. In utero gene therapy: the case against. Nat Med 1999; 5: 255-256.
-
(1999)
Nat. Med.
, vol.5
, pp. 255-256
-
-
Billings, P.R.1
-
108
-
-
0036371236
-
Sustained delivery of therapeutic concentrations of human clotting factor IX - A comparison of adenoviral and AAV vectors administered in utero
-
Schneider H et al. Sustained delivery of therapeutic concentrations of human clotting factor IX - a comparison of adenoviral and AAV vectors administered in utero. J Gene Med 2002; 4: 46-53.
-
(2002)
J. Gene Med.
, vol.4
, pp. 46-53
-
-
Schneider, H.1
-
109
-
-
0034981261
-
In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression
-
Lipshutz GS et al. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 2001; 3: 284-292.
-
(2001)
Mol. Ther.
, vol.3
, pp. 284-292
-
-
Lipshutz, G.S.1
-
110
-
-
0036081135
-
Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice
-
Jerebtsova M, Batshaw ML, Ye X Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice. Pediatr Res 2002; 52: 95-104.
-
(2002)
Pediatr. Res.
, vol.52
, pp. 95-104
-
-
Jerebtsova, M.1
Batshaw, M.L.2
Ye, X.3
|